XENE - Xenon Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

XENE is currently covered by 10 analysts with an average price target of $52.14. This is a potential upside of $12.64 (32%) from yesterday's end of day stock price of $39.5.

Xenon Pharmaceuticals's activity chart (see below) currently has 36 price targets and 76 ratings on display. The stock rating distribution of XENE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.86% with an average time for these price targets to be met of 500 days.

Highest price target for XENE is $62, Lowest price target is $49, average price target is $52.14.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 12-Apr-2024. First documented stock forecast 01-Dec-2014.

Currently out of the existing stock ratings of XENE, 35 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

62

$22.5 (56.96%)

62

13 days ago

8/10 (80%)

$20.7 (50.12%)

450

Buy

51

$11.5 (29.11%)

46

1 months 24 days ago

9/10 (90%)

$4.16 (8.88%)

430

Buy

55

$15.5 (39.24%)

56

1 months 24 days ago

5/11 (45.45%)

$8.16 (17.42%)

492

Buy

56

$16.5 (41.77%)

52

3 months 23 days ago

1/3 (33.33%)

$11.09 (24.69%)

528

Buy

62

$22.5 (56.96%)

44

4 months 7 days ago

3/4 (75%)

$20.85 (50.67%)

512

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is XENE (Xenon Pharmaceuticals) average time for price targets to be met?

On average it took 500 days on average for the stock forecasts to be realized with a an average price target met ratio 60.86

Which analyst has the current highest performing score on XENE (Xenon Pharmaceuticals) with a proven track record?

ANDREW TSAI

Which analyst has the most public recommendations on XENE (Xenon Pharmaceuticals)?

Andrew Tsai works at JEFFERIES and has 6 price targets and 5 ratings on XENE

Which analyst is the currently most bullish on XENE (Xenon Pharmaceuticals)?

Stephen Willey with highest potential upside - $22.5

Which analyst is the currently most reserved on XENE (Xenon Pharmaceuticals)?

Maury Raycroft with lowest potential downside - -$10.24

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?